128 related articles for article (PubMed ID: 19291823)
1. Role of cathepsin B-mediated apoptosis in fulminant hepatic failure in mice.
Yan BZ; Wang W; Chen LY; Bi MR; Lu YJ; Li BX; Yang BS
World J Gastroenterol; 2009 Mar; 15(10):1231-6. PubMed ID: 19291823
[TBL] [Abstract][Full Text] [Related]
2. Hepatoprotective effects of cathepsin B inhibitor on acute hepatic failure induced by lipopolysaccharide/D-galactosamine in mice.
Yan BZ; Chen LY; Kang L; Wang XR; Bi MR; Wang W; Yang BS
Hepatobiliary Pancreat Dis Int; 2013 Feb; 12(1):80-6. PubMed ID: 23392803
[TBL] [Abstract][Full Text] [Related]
3. Cathepsin B inactivation attenuates the apoptotic injury induced by ischemia/reperfusion of mouse liver.
Ben-Ari Z; Mor E; Azarov D; Sulkes J; Tor R; Cheporko Y; Hochhauser E; Pappo O
Apoptosis; 2005 Dec; 10(6):1261-9. PubMed ID: 16215674
[TBL] [Abstract][Full Text] [Related]
4. A role of cell apoptosis in lipopolysaccharide (LPS)-induced nonlethal liver injury in D-galactosamine (D-GalN)-sensitized rats.
Liu LM; Zhang JX; Luo J; Guo HX; Deng H; Chen JY; Sun SL
Dig Dis Sci; 2008 May; 53(5):1316-24. PubMed ID: 17934810
[TBL] [Abstract][Full Text] [Related]
5. Protective effect of linarin against D-galactosamine and lipopolysaccharide-induced fulminant hepatic failure.
Kim SJ; Cho HI; Kim SJ; Park JH; Kim JS; Kim YH; Lee SK; Kwak JH; Lee SM
Eur J Pharmacol; 2014 Sep; 738():66-73. PubMed ID: 24877692
[TBL] [Abstract][Full Text] [Related]
6. Administration of cathepsin B inhibitor CA-074Me reduces inflammation and apoptosis in polymyositis.
Feng Y; Ni L; Wang Q
J Dermatol Sci; 2013 Nov; 72(2):158-67. PubMed ID: 23890703
[TBL] [Abstract][Full Text] [Related]
7. Reduced hepatic injury in Toll-like receptor 4-deficient mice following D-galactosamine/lipopolysaccharide-induced fulminant hepatic failure.
Ben Ari Z; Avlas O; Pappo O; Zilbermints V; Cheporko Y; Bachmetov L; Zemel R; Shainberg A; Sharon E; Grief F; Hochhauser E
Cell Physiol Biochem; 2012; 29(1-2):41-50. PubMed ID: 22415073
[TBL] [Abstract][Full Text] [Related]
8. Role of α-lipoic acid in LPS/d-GalN induced fulminant hepatic failure in mice: studies on oxidative stress, inflammation and apoptosis.
Xia X; Su C; Fu J; Zhang P; Jiang X; Xu D; Hu L; Song E; Song Y
Int Immunopharmacol; 2014 Oct; 22(2):293-302. PubMed ID: 25046589
[TBL] [Abstract][Full Text] [Related]
9. Tumor necrosis factor-alpha induces apoptosis of enterocytes in mice with fulminant hepatic failure.
Song HL; Lu S; Liu P
World J Gastroenterol; 2005 Jun; 11(24):3701-9. PubMed ID: 15968724
[TBL] [Abstract][Full Text] [Related]
10. [The experimental study of specific inhibitor-CA-074Me of Cathepsin B suppressing retinal neovascularization].
Zhou GH; Yu WZ; Li XX
Zhonghua Yan Ke Za Zhi; 2008 Mar; 44(3):207-11. PubMed ID: 18785542
[TBL] [Abstract][Full Text] [Related]
11. Palmatine attenuates D-galactosamine/lipopolysaccharide-induced fulminant hepatic failure in mice.
Lee WC; Kim JK; Kang JW; Oh WY; Jung JY; Kim YS; Jung HA; Choi JS; Lee SM
Food Chem Toxicol; 2010 Jan; 48(1):222-8. PubMed ID: 19818826
[TBL] [Abstract][Full Text] [Related]
12. Protective effect of SKLB010 against D-galactosamine/lipopolysaccharide-induced acute liver failure via nuclear factor-κB signaling pathway in macrophages.
Xie C; Jingjing W; Li X; Zeng F; Ma L; Li C; Wei Z; Peng A; Chen L
Int Immunopharmacol; 2014 Aug; 21(2):261-8. PubMed ID: 24861250
[TBL] [Abstract][Full Text] [Related]
13. [Cathepsin B in hepatic Kupffer cells regulates activation of TLR4-independent inflammatory pathways in mice with lipopolysaccharide-induced sepsis].
Feng P; Zhu W; Chen N; Li P; He K; Gong J
Nan Fang Yi Ke Da Xue Xue Bao; 2018 Dec; 38(12):1465-1471. PubMed ID: 30613015
[TBL] [Abstract][Full Text] [Related]
14. Endogenous AMPK acts as a detrimental factor in fulminant hepatitis via potentiating JNK-dependent hepatocyte apoptosis.
Hu K; Gong X; Ai Q; Lin L; Dai J; Cai L; Jiang R; Ge P; Zhang L
Cell Death Dis; 2017 Mar; 8(3):e2637. PubMed ID: 28252653
[TBL] [Abstract][Full Text] [Related]
15. [Tumor necrosis factor alpha and enterocyte apoptosis in mice with fulminant hepatic failure].
Song HL; Lü S; Liu P
Zhonghua Gan Zang Bing Za Zhi; 2005 Apr; 13(4):290-3. PubMed ID: 15850520
[TBL] [Abstract][Full Text] [Related]
16. Enhanced expressions and activations of leukotriene C4 synthesis enzymes in D-galactosamine/lipopolysaccharide-induced rat fulminant hepatic failure model.
Ma KF; Yang HY; Chen Z; Qi LY; Zhu DY; Lou YJ
World J Gastroenterol; 2008 May; 14(17):2748-56. PubMed ID: 18461660
[TBL] [Abstract][Full Text] [Related]
17. Genipin protects lipopolysaccharide-induced apoptotic liver damage in D-galactosamine-sensitized mice.
Kim SJ; Kim JK; Lee DU; Kwak JH; Lee SM
Eur J Pharmacol; 2010 Jun; 635(1-3):188-93. PubMed ID: 20303938
[TBL] [Abstract][Full Text] [Related]
18. Preliminary research on the pathological role of cathepsin-B in subcutaneous heteroplastic pancreatic carcinoma in nude mice.
Zhang C; Sun JB; Liu DC; Cui YQ; Liu S; Sun HC
Chin Med J (Engl); 2009 Oct; 122(20):2489-96. PubMed ID: 20079165
[TBL] [Abstract][Full Text] [Related]
19. Acute liver injury attenuation of a novel recombinant sTNFR through blocking hepatic apoptosis.
Luo M; Zhao A; Li J; Chen Y; Tian D; Wang C; Hu Z; Gao J
Immunopharmacol Immunotoxicol; 2015 Jun; 37(3):295-300. PubMed ID: 25982795
[TBL] [Abstract][Full Text] [Related]
20. Obeticholic acid differentially regulates hepatic injury and inflammation at different stages of D-galactosamine/lipopolysaccharide-evoked acute liver failure.
Ding W; Fan YY; Zhang C; Fu L; Chen X; Xu DX
Eur J Pharmacol; 2019 May; 850():150-157. PubMed ID: 30772394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]